Catalyst Wire Dossier Catalyst Wire Dossier

adapalene 0.1%

adapalene · Galderma R&D
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for adapalene 0.1%, covering 2011-04-19 to 2011-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% [Phase 3]

See pricing